US 12325708
Adenosine 2 receptor antagonists
granted A61KA61K31/519A61P
Quick answer
US patent 12325708 (Adenosine 2 receptor antagonists) held by Nektar Therapeutics expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/519, A61P, A61P35/00